LEVOFLOXACIN

LEVOFLOXACIN was reported 60948 times

LEVOFLOXACIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CONGENITAL HIATUS HERNIA 112 0.4912
1 SPIROMETRY ABNORMAL 274 0.4582
2 PULMONARY VASCULITIS 243 0.4517
3 MITE ALLERGY 265 0.4046
4 TOTAL LUNG CAPACITY ABNORMAL 149 0.3830
5 MYCOTIC ALLERGY 266 0.3111
6 DUST ALLERGY 270 0.2752
7 CAPILLARITIS 71 0.2572
8 CONJUNCTIVITIS ALLERGIC 282 0.1903
9 SEDATION COMPLICATION 471 0.1844
10 TENDON DISCOMFORT 134 0.1775
11 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 124 0.1692
12 NEURITIS 242 0.1566
13 DISSEMINATED MUCORMYCOSIS 57 0.1447
14 TENDON PAIN 1086 0.1433
15 DYSBIOSIS 113 0.1376
16 DELUSION OF GRANDEUR 61 0.1359
17 CREATININE RENAL CLEARANCE DECREASED 466 0.1163
18 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 206 0.1009
19 NORMOCHROMIC NORMOCYTIC ANAEMIA 301 0.1001
20 TENDON DISORDER 653 0.1000
21 SMALL FIBRE NEUROPATHY 69 0.0935
22 MULTIPLE DRUG THERAPY 69 0.0915
23 COMPUTERISED TOMOGRAM THORAX ABNORMAL 62 0.0902
24 CREATININE RENAL CLEARANCE INCREASED 67 0.0896
25 BLOODY DISCHARGE 100 0.0875
26 RESPIRATORY SYMPTOM 249 0.0875
27 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 89 0.0838
28 REBOUND ACID HYPERSECRETION 244 0.0806
29 CRYSTAL NEPHROPATHY 45 0.0760
30 VASCULAR PURPURA 105 0.0752
31 TENDONITIS 1164 0.0751
32 NEPHROGENIC ANAEMIA 341 0.0735
33 SPUTUM PURULENT 48 0.0729
34 HYPOCOAGULABLE STATE 68 0.0698
35 COLLAGEN DISORDER 39 0.0678
36 HYPERPARATHYROIDISM SECONDARY 166 0.0662
37 FORCED EXPIRATORY VOLUME DECREASED 184 0.0649
38 MALIGNANT MELANOMA IN SITU 80 0.0646
39 INTERNATIONAL NORMALISED RATIO FLUCTUATION 132 0.0637
40 TENDON RUPTURE 777 0.0629
41 CONTRAST MEDIA ALLERGY 113 0.0616
42 SJS-TEN OVERLAP 42 0.0598
43 PULMONARY ALVEOLAR HAEMORRHAGE 306 0.0545
44 THERAPEUTIC PRODUCT CROSS-REACTIVITY 48 0.0538
45 TYPE I HYPERSENSITIVITY 189 0.0536
46 STENOTROPHOMONAS INFECTION 72 0.0531
47 PSEUDOMEMBRANOUS COLITIS 117 0.0523
48 PATHOGEN RESISTANCE 474 0.0520
49 BLOOD CALCIUM DECREASED 510 0.0453
50 LYMPHOCYTE COUNT ABNORMAL 51 0.0453
51 OBLITERATIVE BRONCHIOLITIS 59 0.0449
52 JOINT NOISE 88 0.0448
53 CHRONIC FATIGUE SYNDROME 62 0.0445
54 FULL BLOOD COUNT ABNORMAL 470 0.0444
55 NEUROLOGICAL SYMPTOM 251 0.0439
56 STREPTOCOCCAL SEPSIS 52 0.0438
57 ORTHOSTATIC HYPOTENSION 725 0.0416
58 FUNGAEMIA 63 0.0400
59 END STAGE RENAL DISEASE 722 0.0395
60 ARTERIOSCLEROSIS CORONARY ARTERY 243 0.0366
61 NORMOCYTIC ANAEMIA 52 0.0354
62 OBSTRUCTIVE AIRWAYS DISORDER 392 0.0352
63 MEGACOLON 54 0.0344
64 FIXED ERUPTION 57 0.0331
65 PNEUMONIA LEGIONELLA 53 0.0331
66 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 846 0.0328
67 BENIGN PROSTATIC HYPERPLASIA 169 0.0327
68 MUCORMYCOSIS 81 0.0311
69 ARTERIOSCLEROSIS 293 0.0311
70 TENDON INJURY 115 0.0309
71 BREATH SOUNDS ABNORMAL 151 0.0306
72 CHRONIC KIDNEY DISEASE 2293 0.0301
73 PNEUMONIA FUNGAL 119 0.0301
74 LONG QT SYNDROME 71 0.0296
75 MIXED LIVER INJURY 88 0.0292
76 JOINT CREPITATION 57 0.0287
77 BRONCHOPULMONARY ASPERGILLOSIS 221 0.0285
78 LYME DISEASE 95 0.0285
79 VASCULITIS 326 0.0280
80 CLOSTRIDIUM DIFFICILE COLITIS 291 0.0274
81 PNEUMONIA PSEUDOMONAL 42 0.0274
82 LOSS OF EMPLOYMENT 82 0.0271
83 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 135 0.0271
84 MULTIPLE-DRUG RESISTANCE 82 0.0264
85 BRONCHIECTASIS 178 0.0264
86 PSEUDOMONAL SEPSIS 46 0.0262
87 EOSINOPHILIC PNEUMONIA 80 0.0254
88 TORSADE DE POINTES 198 0.0252
89 OPTIC NEUROPATHY 53 0.0250
90 LIP OEDEMA 106 0.0250
91 KLEBSIELLA INFECTION 126 0.0249
92 PARADOXICAL DRUG REACTION 91 0.0247
93 STRONGYLOIDIASIS 39 0.0241
94 LINEAR IGA DISEASE 40 0.0240
95 TOXIC EPIDERMAL NECROLYSIS 365 0.0240
96 ENTEROCOCCAL INFECTION 116 0.0240
97 ACUTE MYELOID LEUKAEMIA RECURRENT 51 0.0237
98 HEPATITIS CHOLESTATIC 143 0.0237
99 WEIGHT BEARING DIFFICULTY 63 0.0234
100 KOUNIS SYNDROME 53 0.0233
101 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 392 0.0231
102 NOCARDIOSIS 58 0.0227
103 TUBULOINTERSTITIAL NEPHRITIS 414 0.0221
104 NODULE 287 0.0220
105 RENAL TUBULAR NECROSIS 215 0.0219
106 MUSCLE CONTRACTIONS INVOLUNTARY 76 0.0216
107 SYSTEMIC CANDIDA 54 0.0215
108 PLANTAR FASCIITIS 72 0.0214
109 FOOD INTOLERANCE 78 0.0213
110 OTOTOXICITY 39 0.0211
111 FEBRILE NEUTROPENIA 1391 0.0209
112 MYOCLONUS 248 0.0208
113 CHOLESTATIC LIVER INJURY 46 0.0206
114 ATELECTASIS 198 0.0205
115 CONJUNCTIVAL HYPERAEMIA 73 0.0205
116 RENAL FUNCTION TEST ABNORMAL 95 0.0204
117 ESCHERICHIA BACTERAEMIA 48 0.0204
118 SEDATION 531 0.0203
119 GRAFT VERSUS HOST DISEASE IN SKIN 44 0.0200
120 HYPOXIA 701 0.0199
121 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 55 0.0199
122 RASH MORBILLIFORM 55 0.0198
123 DRUG RESISTANCE 509 0.0198
124 BILIRUBIN CONJUGATED INCREASED 46 0.0197
125 RHINALGIA 54 0.0196
126 EOSINOPHILIA 340 0.0194
127 ELECTROCARDIOGRAM QT PROLONGED 690 0.0192
128 PSEUDOMONAS INFECTION 164 0.0191
129 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 104 0.0191
130 HYPOGLYCAEMIC COMA 55 0.0191
131 ASPERGILLUS INFECTION 125 0.0190
132 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 147 0.0189
133 BRONCHITIS CHRONIC 46 0.0188
134 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 40 0.0188
135 APLASTIC ANAEMIA 98 0.0187
136 VASCULAR DEVICE INFECTION 85 0.0187
137 DERMATITIS EXFOLIATIVE GENERALISED 65 0.0187
138 HISTIOCYTOSIS HAEMATOPHAGIC 55 0.0185
139 HEPATIC CYTOLYSIS 233 0.0183
140 DUODENITIS 56 0.0182
141 RASH MACULO-PAPULAR 398 0.0179
142 TOXIC SKIN ERUPTION 180 0.0179
143 CHOLESTASIS 343 0.0178
144 HENOCH-SCHONLEIN PURPURA 39 0.0178
145 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 133 0.0177
146 HEPATITIS TOXIC 46 0.0176
147 CLOSTRIDIAL INFECTION 59 0.0174
148 ACUTE KIDNEY INJURY 2667 0.0174
149 TENOSYNOVITIS 48 0.0174
150 DEPRESSED LEVEL OF CONSCIOUSNESS 688 0.0174
151 IRON DEFICIENCY 78 0.0173
152 CUTANEOUS VASCULITIS 63 0.0172
153 TONGUE OEDEMA 65 0.0170
154 PULMONARY FIBROSIS 323 0.0168
155 LUNG CONSOLIDATION 47 0.0168
156 BRAIN ABSCESS 42 0.0166
157 OLIGURIA 102 0.0164
158 DISSEMINATED TUBERCULOSIS 42 0.0164
159 HYPERURICAEMIA 67 0.0163
160 CANDIDA INFECTION 275 0.0163
161 BACTERIAL SEPSIS 53 0.0163
162 MUSCLE RUPTURE 63 0.0162
163 HAEMOPTYSIS 448 0.0160
164 MYCOBACTERIUM AVIUM COMPLEX INFECTION 43 0.0160
165 HYPERSENSITIVITY VASCULITIS 42 0.0160
166 CHRONIC SINUSITIS 60 0.0160
167 HYPERBILIRUBINAEMIA 165 0.0159
168 AFFECTIVE DISORDER 125 0.0159
169 HYPERLACTACIDAEMIA 42 0.0156
170 PURPURA 138 0.0156
171 COGNITIVE DISORDER 728 0.0156
172 MULTIPLE ORGAN DYSFUNCTION SYNDROME 438 0.0154
173 PRODUCTIVE COUGH 738 0.0154
174 CYTOKINE RELEASE SYNDROME 309 0.0154
175 BACTERAEMIA 180 0.0152
176 SEPTIC SHOCK 655 0.0150
177 PNEUMONIA BACTERIAL 138 0.0150
178 CYSTIC FIBROSIS 83 0.0150
179 AORTIC ANEURYSM 113 0.0148
180 DRUG-INDUCED LIVER INJURY 465 0.0148
181 HYPOALBUMINAEMIA 114 0.0146
182 EXERCISE TOLERANCE DECREASED 84 0.0146
183 CLOSTRIDIUM DIFFICILE INFECTION 318 0.0146
184 RENAL INJURY 425 0.0143
185 CYTOMEGALOVIRUS INFECTION REACTIVATION 63 0.0142
186 SPUTUM DISCOLOURED 135 0.0142
187 HYPERPYREXIA 60 0.0142
188 NEUROTOXICITY 248 0.0141
189 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 54 0.0141
190 MUCOSAL INFLAMMATION 370 0.0141
191 HEPATIC NECROSIS 53 0.0141
192 RHINOVIRUS INFECTION 54 0.0139
193 ESCHERICHIA INFECTION 114 0.0138
194 COVID-19 PNEUMONIA 163 0.0138
195 TOXIC ENCEPHALOPATHY 69 0.0136
196 STAPHYLOCOCCAL SEPSIS 67 0.0136
197 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 80 0.0135
198 GRAFT VERSUS HOST DISEASE 97 0.0135
199 RENAL FAILURE 1791 0.0135
200 ENTEROCOLITIS 77 0.0133
201 TESTICULAR PAIN 42 0.0132
202 HYDROCEPHALUS 72 0.0132
203 CYSTITIS HAEMORRHAGIC 53 0.0131
204 BLOOD BILIRUBIN INCREASED 355 0.0131
205 DERMATITIS BULLOUS 95 0.0131
206 POLYNEUROPATHY 157 0.0131
207 ACUTE GRAFT VERSUS HOST DISEASE 60 0.0131
208 AGRANULOCYTOSIS 241 0.0130
209 ACUTE MYELOID LEUKAEMIA 202 0.0129
210 NEUROPATHY PERIPHERAL 1229 0.0129
211 PULMONARY TUBERCULOSIS 55 0.0129
212 PNEUMOCYSTIS JIROVECII PNEUMONIA 129 0.0128
213 MUSCLE ATROPHY 161 0.0127
214 WHEEZING 753 0.0127
215 GUILLAIN-BARRE SYNDROME 61 0.0126
216 AORTIC DISSECTION 52 0.0125
217 PERIPHERAL SENSORY NEUROPATHY 73 0.0125
218 HAEMODYNAMIC INSTABILITY 95 0.0125
219 RESPIRATORY ACIDOSIS 49 0.0125
220 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 595 0.0124
221 PANCYTOPENIA 691 0.0124
222 LIVER ABSCESS 40 0.0123
223 STAPHYLOCOCCAL BACTERAEMIA 53 0.0122
224 HYPOMAGNESAEMIA 169 0.0121
225 HYPERTRANSAMINASAEMIA 84 0.0121
226 VENTRICULAR ARRHYTHMIA 44 0.0120
227 ENDOPHTHALMITIS 72 0.0120
228 LEUKOCYTOSIS 216 0.0119
229 ACUTE RESPIRATORY DISTRESS SYNDROME 210 0.0119
230 STATUS EPILEPTICUS 134 0.0119
231 HYPERCHOLESTEROLAEMIA 114 0.0118
232 THROMBOCYTOPENIA 1317 0.0118
233 ENCEPHALOPATHY 286 0.0116
234 PNEUMONITIS 315 0.0116
235 OESOPHAGEAL CANDIDIASIS 46 0.0115
236 VENOOCCLUSIVE LIVER DISEASE 57 0.0115
237 LYMPHOCYTE COUNT DECREASED 204 0.0115
238 NEUTROPHIL COUNT INCREASED 118 0.0115
239 RESPIRATORY FAILURE 840 0.0115
240 CYTOMEGALOVIRUS VIRAEMIA 51 0.0115
241 HYPOKALAEMIA 529 0.0114
242 INTERNATIONAL NORMALISED RATIO INCREASED 326 0.0114
243 BLOOD LACTATE DEHYDROGENASE INCREASED 178 0.0112
244 ACUTE RESPIRATORY FAILURE 216 0.0112
245 MICTURITION URGENCY 128 0.0112
246 HEPATOTOXICITY 249 0.0112
247 DELIRIUM 387 0.0111
248 CYTOPENIA 135 0.0110
249 PNEUMOTHORAX 174 0.0110
250 HYPOVOLAEMIC SHOCK 52 0.0108
251 DRUG ERUPTION 192 0.0108
252 C-REACTIVE PROTEIN INCREASED 394 0.0108
253 CHRONIC GRAFT VERSUS HOST DISEASE 39 0.0108
254 DISSEMINATED INTRAVASCULAR COAGULATION 150 0.0106
255 ECCHYMOSIS 73 0.0106
256 PROTEIN TOTAL DECREASED 40 0.0106
257 HYPOTHYROIDISM 334 0.0104
258 DRUG INTERACTION 1642 0.0103
259 CYTOMEGALOVIRUS INFECTION 172 0.0103
260 STEVENS-JOHNSON SYNDROME 230 0.0103
261 VARICOSE VEIN 53 0.0103
262 PARONYCHIA 45 0.0102
263 ECONOMIC PROBLEM 155 0.0102
264 CHOLANGITIS 63 0.0102
265 HOSPICE CARE 100 0.0101
266 ODYNOPHAGIA 60 0.0100
267 STAPHYLOCOCCAL INFECTION 331 0.0100
268 AZOTAEMIA 40 0.0100
269 NEPHROPATHY TOXIC 112 0.0100
270 ASPARTATE AMINOTRANSFERASE INCREASED 527 0.0099
271 BACTERIAL INFECTION 185 0.0099
272 LARYNGEAL OEDEMA 61 0.0099
273 HAEMATOTOXICITY 94 0.0099
274 ENTERITIS 63 0.0098
275 RESPIRATORY DISTRESS 270 0.0098
276 TUMOUR LYSIS SYNDROME 86 0.0098
277 MOBILITY DECREASED 702 0.0098
278 ROTATOR CUFF SYNDROME 125 0.0097
279 LUNG INFECTION 151 0.0097
280 CACHEXIA 50 0.0097
281 NEURALGIA 236 0.0097
282 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 690 0.0097
283 LEUKOPENIA 485 0.0097
284 INFLAMMATORY MARKER INCREASED 48 0.0097
285 TRANSAMINASES INCREASED 215 0.0097
286 RESPIRATORY TRACT INFECTION 251 0.0096
287 LUNG DISORDER 472 0.0096
288 LUNG INFILTRATION 85 0.0096
289 ORAL CANDIDIASIS 126 0.0096
290 NEUTROPHIL COUNT DECREASED 389 0.0095
291 HEPATITIS ACUTE 62 0.0095
292 RALES 55 0.0095
293 THROMBOTIC MICROANGIOPATHY 92 0.0094
294 NEUTROPENIA 1281 0.0094
295 ANHEDONIA 247 0.0094
296 BLOOD ALKALINE PHOSPHATASE INCREASED 233 0.0094
297 HEPATOCELLULAR INJURY 133 0.0094
298 ALANINE AMINOTRANSFERASE INCREASED 572 0.0093
299 PNEUMONIA 3015 0.0093
300 SUPRAVENTRICULAR TACHYCARDIA 89 0.0093
301 ORGANISING PNEUMONIA 46 0.0093
302 VENTRICULAR FIBRILLATION 103 0.0093
303 ERYTHEMA MULTIFORME 86 0.0092
304 HYPERAMMONAEMIA 46 0.0092
305 MUSCLE TIGHTNESS 149 0.0092
306 NASAL POLYPS 45 0.0091
307 SEPSIS 1019 0.0091
308 METABOLIC ACIDOSIS 291 0.0091
309 HYPOPHOSPHATAEMIA 67 0.0091
310 HYPOGLYCAEMIA 438 0.0090
311 PYELONEPHRITIS 78 0.0090
312 WHEELCHAIR USER 40 0.0090
313 DERMATITIS EXFOLIATIVE 45 0.0090
314 INTRACRANIAL PRESSURE INCREASED 50 0.0090
315 ENDOCARDITIS 46 0.0090
316 VENTRICULAR TACHYCARDIA 148 0.0090
317 ERYSIPELAS 45 0.0089
318 BALANCE DISORDER 772 0.0089
319 DYSPHEMIA 39 0.0089
320 NEPHROPATHY 83 0.0089
321 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 91 0.0089
322 PROTHROMBIN TIME PROLONGED 53 0.0089
323 URINE OUTPUT DECREASED 77 0.0088
324 BRAIN OEDEMA 111 0.0088
325 UPPER RESPIRATORY TRACT INFECTION 405 0.0088
326 PLEURAL EFFUSION 533 0.0088
327 TACHYPNOEA 119 0.0087
328 IMMUNE THROMBOCYTOPENIA 40 0.0087
329 BLOOD UREA INCREASED 146 0.0087
330 ANURIA 75 0.0087
331 ELECTROLYTE IMBALANCE 101 0.0087
332 MULTI-ORGAN FAILURE 149 0.0086
333 GAMMA-GLUTAMYLTRANSFERASE INCREASED 191 0.0086
334 PULMONARY HAEMORRHAGE 67 0.0086
335 PETECHIAE 89 0.0085
336 IMPAIRED WORK ABILITY 182 0.0085
337 HEPATIC FUNCTION ABNORMAL 317 0.0085
338 PULMONARY TOXICITY 60 0.0085
339 RHABDOMYOLYSIS 353 0.0085
340 MUSCULOSKELETAL PAIN 439 0.0084
341 LYMPHOPENIA 118 0.0083
342 BLOOD ALBUMIN DECREASED 66 0.0083
343 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 42 0.0083
344 FAILURE TO THRIVE 43 0.0083
345 NERVE INJURY 92 0.0083
346 NERVOUS SYSTEM DISORDER 258 0.0083
347 HYPERNATRAEMIA 41 0.0082
348 SECRETION DISCHARGE 103 0.0082
349 HAEMATOMA 213 0.0082
350 PYREXIA 2841 0.0082
351 ACUTE HEPATIC FAILURE 112 0.0082
352 BLOOD URIC ACID INCREASED 47 0.0081
353 CARDIAC FAILURE ACUTE 54 0.0081
354 HEPATITIS 207 0.0081
355 GENERALISED ERYTHEMA 46 0.0081
356 PLATELET COUNT DECREASED 860 0.0081
357 MYASTHENIA GRAVIS 65 0.0080
358 ATRIAL FLUTTER 64 0.0080
359 FACE OEDEMA 135 0.0080
360 HYPOCALCAEMIA 151 0.0080
361 GINGIVITIS 43 0.0080
362 COAGULOPATHY 132 0.0079
363 HICCUPS 65 0.0079
364 PLEURISY 47 0.0079
365 LEFT VENTRICULAR DYSFUNCTION 53 0.0079
366 HALLUCINATION, VISUAL 167 0.0079
367 ANAEMIA 1493 0.0078
368 BLOOD CREATININE INCREASED 507 0.0078
369 ASTHMA 876 0.0077
370 ALTERED STATE OF CONSCIOUSNESS 167 0.0077
371 HAEMOLYTIC ANAEMIA 69 0.0077
372 HEPATIC STEATOSIS 143 0.0077
373 MENTAL STATUS CHANGES 213 0.0077
374 PULMONARY EMBOLISM 728 0.0077
375 OESOPHAGITIS 83 0.0076
376 BLOOD COUNT ABNORMAL 115 0.0076
377 HIATUS HERNIA 98 0.0076
378 STREPTOCOCCAL INFECTION 42 0.0075
379 DYSPNOEA EXERTIONAL 284 0.0075
380 SINUS TACHYCARDIA 107 0.0075
381 VITREOUS FLOATERS 74 0.0075
382 MYOPATHY 65 0.0075
383 PULMONARY MASS 111 0.0074
384 TRANSFUSION 78 0.0074
385 TINNITUS 342 0.0074
386 CHOLECYSTITIS ACUTE 42 0.0074
387 HYPOTENSION 1484 0.0074
388 MUSCULOSKELETAL DISCOMFORT 127 0.0074
389 MUSCULAR WEAKNESS 837 0.0074
390 RESPIRATORY DISORDER 219 0.0073
391 PLATELET COUNT INCREASED 95 0.0073
392 JAUNDICE 196 0.0073
393 SUDDEN DEATH 77 0.0073
394 MYALGIA 1237 0.0073
395 METASTASES TO LYMPH NODES 49 0.0073
396 INGUINAL HERNIA 44 0.0072
397 GASTROOESOPHAGEAL REFLUX DISEASE 579 0.0072
398 RENAL FAILURE ACUTE 305 0.0072
399 JOINT INJURY 153 0.0072
400 PAROSMIA 54 0.0071
401 PSYCHOTIC DISORDER 211 0.0071
402 PERIPHERAL COLDNESS 98 0.0071
403 CONCOMITANT DISEASE AGGRAVATED 44 0.0071
404 GASTROENTERITIS 104 0.0071
405 SHOCK HAEMORRHAGIC 58 0.0071
406 MUSCLE TWITCHING 164 0.0071
407 SKIN HYPERPIGMENTATION 61 0.0071
408 GENERALISED TONIC-CLONIC SEIZURE 117 0.0071
409 OSTEOPENIA 107 0.0070
410 FULL BLOOD COUNT DECREASED 142 0.0070
411 RENAL IMPAIRMENT 592 0.0070
412 EPSTEIN-BARR VIRUS INFECTION 44 0.0070
413 DISORIENTATION 279 0.0070
414 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 62 0.0070
415 PERICARDIAL EFFUSION 162 0.0070
416 DECUBITUS ULCER 57 0.0070
417 PAPULE 49 0.0069
418 WHITE BLOOD CELL COUNT DECREASED 749 0.0069
419 SKIN TOXICITY 39 0.0069
420 DEVICE RELATED INFECTION 106 0.0069
421 SHOCK 158 0.0069
422 NEUTROPENIC SEPSIS 49 0.0069
423 HALLUCINATION, AUDITORY 109 0.0069
424 PANIC ATTACK 249 0.0068
425 OEDEMA 368 0.0068
426 HERPES VIRUS INFECTION 39 0.0068
427 PAIN IN EXTREMITY 1994 0.0068
428 LOWER GASTROINTESTINAL HAEMORRHAGE 50 0.0068
429 ILEUS 84 0.0068
430 SKIN LESION 185 0.0067
431 HYPONATRAEMIA 379 0.0067
432 BONE MARROW FAILURE 136 0.0067
433 MALNUTRITION 74 0.0066
434 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 345 0.0066
435 MENINGITIS 44 0.0066
436 BRONCHITIS 487 0.0066
437 CONTRAINDICATED PRODUCT ADMINISTERED 199 0.0066
438 TACHYCARDIA 583 0.0066
439 HYPERTHERMIA 50 0.0065
440 BLADDER DISORDER 65 0.0065
441 GENERALISED OEDEMA 81 0.0065
442 EMPHYSEMA 66 0.0065
443 CELLULITIS 329 0.0065
444 JOINT EFFUSION 45 0.0065
445 WHITE BLOOD CELL COUNT INCREASED 250 0.0065
446 INTERSTITIAL LUNG DISEASE 315 0.0065
447 UROSEPSIS 60 0.0065
448 LARGE INTESTINE PERFORATION 45 0.0065
449 FORMICATION 45 0.0065
450 MELAENA 142 0.0064
451 MITRAL VALVE INCOMPETENCE 73 0.0064
452 HEPATIC ENCEPHALOPATHY 60 0.0064
453 RED BLOOD CELL SEDIMENTATION RATE INCREASED 71 0.0064
454 DYSSTASIA 187 0.0064
455 OPTIC NEURITIS 58 0.0064
456 LIVER DISORDER 283 0.0064
457 HEPATIC FAILURE 192 0.0064
458 ENCEPHALITIS 44 0.0064
459 PIGMENTATION DISORDER 39 0.0063
460 THROMBOSIS 505 0.0063
461 SCHIZOPHRENIA 76 0.0062
462 HYPOGAMMAGLOBULINAEMIA 41 0.0062
463 EOSINOPHIL COUNT INCREASED 52 0.0062
464 SENSORY DISTURBANCE 100 0.0062
465 PEMPHIGOID 47 0.0062
466 GAIT INABILITY 208 0.0062
467 WALKING AID USER 41 0.0062
468 INFECTION 898 0.0062
469 HAEMATURIA 212 0.0062
470 BURSITIS 75 0.0062
471 RESTLESSNESS 226 0.0062
472 ANGIOEDEMA 273 0.0062
473 RENAL CYST 49 0.0062
474 TENDERNESS 64 0.0061
475 PHOTOPHOBIA 115 0.0061
476 RENAL FAILURE CHRONIC 47 0.0061
477 QUALITY OF LIFE DECREASED 82 0.0061
478 LIVER INJURY 149 0.0061
479 VENTRICULAR EXTRASYSTOLES 63 0.0061
480 TREATMENT FAILURE 502 0.0061
481 RETINAL HAEMORRHAGE 43 0.0060
482 HYDRONEPHROSIS 45 0.0060
483 CORONARY ARTERY DISEASE 182 0.0060
484 SUBDURAL HAEMATOMA 86 0.0060
485 CONSTIPATION 1310 0.0060
486 PNEUMONIA ASPIRATION 150 0.0060
487 SARS-COV-2 TEST POSITIVE 79 0.0060
488 HYPERKALAEMIA 207 0.0059
489 MUSCLE STRAIN 51 0.0059
490 AUTOIMMUNE HEPATITIS 41 0.0059
491 BLOOD SODIUM DECREASED 111 0.0059
492 EXTRASYSTOLES 41 0.0059
493 EYE INFLAMMATION 56 0.0059
494 MULTIPLE ALLERGIES 46 0.0059
495 RESPIRATORY SYNCYTIAL VIRUS INFECTION 51 0.0059
496 IMPAIRED QUALITY OF LIFE 84 0.0058
497 HAEMOLYSIS 45 0.0058
498 BLOOD PRESSURE DIASTOLIC DECREASED 43 0.0058
499 EPILEPSY 178 0.0058
500 JOINT RANGE OF MOTION DECREASED 78 0.0058
501 HYPOTONIA 58 0.0058
502 RED BLOOD CELL COUNT DECREASED 166 0.0058
503 BLOOD MAGNESIUM DECREASED 50 0.0058
504 CONFUSIONAL STATE 935 0.0058
505 RESPIRATORY RATE INCREASED 51 0.0057
506 UPPER GASTROINTESTINAL HAEMORRHAGE 96 0.0057
507 SPINAL OSTEOARTHRITIS 50 0.0057
508 PRESYNCOPE 138 0.0057
509 ARTHRALGIA 2359 0.0057
510 DRUG INTOLERANCE 548 0.0057
511 HAEMOGLOBIN DECREASED 582 0.0057
512 OROPHARYNGEAL DISCOMFORT 51 0.0056
513 IRON DEFICIENCY ANAEMIA 52 0.0056
514 RASH PUSTULAR 41 0.0056
515 BRAIN FOG 88 0.0056
516 ABNORMAL FAECES 46 0.0056
517 FUNGAL INFECTION 187 0.0056
518 PANCREATITIS ACUTE 126 0.0056
519 INFUSION SITE ERYTHEMA 47 0.0056
520 DECREASED ACTIVITY 60 0.0056
521 GASTROINTESTINAL DISORDER 498 0.0056
522 SPLENOMEGALY 65 0.0055
523 CIRCULATORY COLLAPSE 94 0.0055
524 ARRHYTHMIA 261 0.0055
525 HYPERGLYCAEMIA 200 0.0055
526 PHARYNGITIS 68 0.0055
527 HAEMODIALYSIS 46 0.0055
528 PARAESTHESIA ORAL 79 0.0055
529 CONDITION AGGRAVATED 1663 0.0055
530 DYSPNOEA 3092 0.0055
531 IMMUNOSUPPRESSION 48 0.0054
532 SEASONAL ALLERGY 77 0.0054
533 PARAESTHESIA 852 0.0054
534 SUBARACHNOID HAEMORRHAGE 55 0.0054
535 LYMPHADENOPATHY 191 0.0054
536 MYELODYSPLASTIC SYNDROME 78 0.0054
537 CARDIOMEGALY 66 0.0054
538 ATRIAL FIBRILLATION 522 0.0054
539 GASTRITIS 141 0.0054
540 HAEMARTHROSIS 48 0.0054
541 SLEEP DISORDER 378 0.0054
542 DYSURIA 197 0.0053
543 MYOSITIS 48 0.0053
544 HYPERCALCAEMIA 66 0.0053
545 PHOTOSENSITIVITY REACTION 88 0.0053
546 GAIT DISTURBANCE 1018 0.0053
547 URINARY RETENTION 177 0.0053
548 RIB FRACTURE 109 0.0053
549 MUSCLE RIGIDITY 63 0.0053
550 OXYGEN SATURATION DECREASED 296 0.0053
551 RASH ERYTHEMATOUS 251 0.0052
552 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 288 0.0052
553 GASTROINTESTINAL INFECTION 47 0.0052
554 TOXICITY TO VARIOUS AGENTS 883 0.0052
555 MUSCULOSKELETAL CHEST PAIN 81 0.0052
556 CARDIAC FAILURE 418 0.0052
557 DRUG LEVEL INCREASED 86 0.0052
558 HAEMATOCRIT DECREASED 103 0.0052
559 DIFFUSE LARGE B-CELL LYMPHOMA 40 0.0052
560 GOUT 93 0.0052
561 BODY TEMPERATURE DECREASED 51 0.0052
562 PLASMA CELL MYELOMA 202 0.0052
563 SKIN INFECTION 58 0.0052
564 JOINT STIFFNESS 135 0.0051
565 ABASIA 127 0.0051
566 ABSCESS 82 0.0051
567 DIARRHOEA HAEMORRHAGIC 48 0.0051
568 HYPOAESTHESIA 766 0.0051
569 BRONCHOSPASM 73 0.0051
570 PARALYSIS 73 0.0051
571 ANXIETY 1448 0.0051
572 OSTEOMYELITIS 92 0.0051
573 EYELID OEDEMA 59 0.0051
574 HALLUCINATION 381 0.0051
575 LIVER FUNCTION TEST ABNORMAL 147 0.0050
576 DISEASE PROGRESSION 597 0.0050
577 FACIAL PARALYSIS 43 0.0050
578 BEDRIDDEN 66 0.0050
579 URINARY TRACT INFECTION 856 0.0050
580 APHONIA 70 0.0050
581 FLANK PAIN 47 0.0050
582 ANAPHYLACTIC REACTION 277 0.0050
583 ACIDOSIS 38 0.0050
584 APHASIA 150 0.0050
585 RHINITIS 40 0.0050
586 LIMB DISCOMFORT 153 0.0049
587 ADRENAL INSUFFICIENCY 60 0.0049
588 INTESTINAL PERFORATION 55 0.0049
589 PULMONARY OEDEMA 219 0.0049
590 FLUID OVERLOAD 71 0.0049
591 SEROTONIN SYNDROME 93 0.0048
592 NIGHT SWEATS 156 0.0048
593 COUGH 1357 0.0048
594 DYSPHAGIA 458 0.0048
595 TRANSIENT ISCHAEMIC ATTACK 162 0.0048
596 JOINT SWELLING 579 0.0048
597 BLOOD POTASSIUM DECREASED 144 0.0048
598 CARDIAC ARREST 395 0.0048
599 DERMATITIS 100 0.0048
600 BLOOD PRESSURE SYSTOLIC INCREASED 93 0.0048
601 OEDEMA PERIPHERAL 580 0.0048
602 PULMONARY HYPERTENSION 99 0.0047
603 ASTHENIA 1782 0.0047
604 MOVEMENT DISORDER 152 0.0047
605 STOMATITIS 287 0.0047
606 BURNING SENSATION 331 0.0047
607 SEIZURE 545 0.0047
608 OSTEOPOROSIS 194 0.0047
609 CHROMATURIA 106 0.0047
610 HAEMORRHAGE INTRACRANIAL 70 0.0047
611 EAR DISCOMFORT 48 0.0047
612 CARDIOVASCULAR DISORDER 118 0.0046
613 LOCALISED INFECTION 112 0.0046
614 DRUG LEVEL DECREASED 47 0.0046
615 DERMATITIS ALLERGIC 58 0.0046
616 DECREASED IMMUNE RESPONSIVENESS 45 0.0046
617 DECREASED APPETITE 1063 0.0046
618 WOUND INFECTION 50 0.0046
619 LEUKAEMIA 43 0.0046
620 IMPAIRED GASTRIC EMPTYING 62 0.0045
621 JOINT DISLOCATION 48 0.0045
622 ADVERSE REACTION 60 0.0045
623 DISTURBANCE IN ATTENTION 244 0.0045
624 AUTOIMMUNE DISORDER 44 0.0045
625 HERPES ZOSTER 259 0.0045
626 PULMONARY THROMBOSIS 49 0.0045
627 SKIN REACTION 63 0.0045
628 CARDIO-RESPIRATORY ARREST 187 0.0045
629 MEDICATION ERROR 248 0.0045
630 SWOLLEN TONGUE 139 0.0044
631 CYSTITIS 141 0.0044
632 VITAMIN D DEFICIENCY 43 0.0044
633 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 42 0.0044
634 DYSPHONIA 256 0.0044
635 CHEST DISCOMFORT 448 0.0044
636 BLOOD POTASSIUM INCREASED 71 0.0044
637 VIRAL INFECTION 145 0.0044
638 LACTIC ACIDOSIS 141 0.0043
639 BLOOD CREATINE PHOSPHOKINASE INCREASED 125 0.0043
640 ANAL INCONTINENCE 39 0.0043
641 MANIA 71 0.0043
642 CONJUNCTIVITIS 80 0.0043
643 ANAPHYLACTIC SHOCK 111 0.0043
644 HYPOPHAGIA 110 0.0043
645 COLITIS 163 0.0043
646 ACTIVITIES OF DAILY LIVING IMPAIRED 85 0.0043
647 INFUSION RELATED REACTION 284 0.0043
648 MOUTH ULCERATION 90 0.0043
649 SINUSITIS 437 0.0043
650 CARDIOMYOPATHY 63 0.0043
651 MUSCULOSKELETAL STIFFNESS 373 0.0043
652 MYELOSUPPRESSION 153 0.0042
653 SINUS DISORDER 84 0.0042
654 DEHYDRATION 562 0.0042
655 HYPOKINESIA 61 0.0042
656 HEPATIC ENZYME INCREASED 286 0.0042
657 TASTE DISORDER 85 0.0042
658 ASCITES 123 0.0042
659 SPINAL PAIN 49 0.0042
660 FALL 1389 0.0042
661 HEPATOMEGALY 41 0.0042
662 TOOTH INFECTION 55 0.0042
663 NECK PAIN 233 0.0042
664 VOMITING 1959 0.0042
665 LOWER RESPIRATORY TRACT INFECTION 189 0.0042
666 AGITATION 305 0.0041
667 GASTROINTESTINAL HAEMORRHAGE 347 0.0041
668 MUSCULOSKELETAL DISORDER 79 0.0041
669 SMALL INTESTINAL OBSTRUCTION 51 0.0041
670 SKIN ULCER 107 0.0041
671 INSOMNIA 1100 0.0041
672 RASH PRURITIC 223 0.0041
673 DRUG TOXICITY 56 0.0041
674 METASTASES TO CENTRAL NERVOUS SYSTEM 53 0.0041
675 CHILLS 481 0.0041
676 LIVER FUNCTION TEST INCREASED 88 0.0041
677 BACK PAIN 952 0.0041
678 PAIN 2494 0.0041
679 HYPERTENSION 859 0.0041
680 DEAFNESS 106 0.0040
681 DEEP VEIN THROMBOSIS 263 0.0040
682 CARDIAC FAILURE CONGESTIVE 325 0.0040
683 NIGHTMARE 140 0.0040
684 GENERAL PHYSICAL HEALTH DETERIORATION 467 0.0040
685 VISUAL ACUITY REDUCED 134 0.0040
686 THROAT TIGHTNESS 109 0.0040
687 EXTRAPYRAMIDAL DISORDER 100 0.0040
688 BLISTER 226 0.0040
689 EAR PAIN 78 0.0040
690 DIARRHOEA 2586 0.0040
691 SINUS CONGESTION 54 0.0040
692 BONE PAIN 234 0.0040
693 RASH 1733 0.0040
694 SWELLING 369 0.0039
695 INFLAMMATION 203 0.0039
696 CEREBRAL INFARCTION 96 0.0039
697 BONE DENSITY DECREASED 123 0.0039
698 PAIN IN JAW 111 0.0039
699 BLOOD TEST ABNORMAL 55 0.0039
700 UNRESPONSIVE TO STIMULI 101 0.0039
701 CEREBRAL HAEMORRHAGE 140 0.0039
702 MENTAL DISORDER 170 0.0039
703 PRURITUS GENERALISED 84 0.0039
704 TREMOR 643 0.0039
705 BODY TEMPERATURE INCREASED 79 0.0039
706 NEOPLASM PROGRESSION 134 0.0038
707 OFF LABEL USE 3365 0.0038
708 ORAL PAIN 86 0.0038
709 PROTEINURIA 73 0.0038
710 HEART RATE IRREGULAR 86 0.0038
711 PALPITATIONS 445 0.0038
712 URTICARIA 636 0.0038
713 FOOT DEFORMITY 42 0.0038
714 LOCAL SWELLING 66 0.0038
715 EPISTAXIS 283 0.0038
716 OSTEOARTHRITIS 160 0.0038
717 RENAL PAIN 40 0.0038
718 SKIN EXFOLIATION 317 0.0038
719 HAEMATEMESIS 95 0.0037
720 COLD SWEAT 66 0.0037
721 FAECES DISCOLOURED 81 0.0037
722 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 87 0.0037
723 INFUSION SITE PAIN 48 0.0037
724 ABDOMINAL PAIN 866 0.0037
725 NAUSEA 2945 0.0037
726 EAR INFECTION 99 0.0037
727 PERITONITIS 77 0.0037
728 POOR QUALITY SLEEP 80 0.0037
729 URINARY INCONTINENCE 110 0.0037
730 MYOCARDIAL ISCHAEMIA 42 0.0037
731 PSYCHOMOTOR HYPERACTIVITY 61 0.0037
732 HEPATIC CIRRHOSIS 69 0.0037
733 HYPERSENSITIVITY 680 0.0037
734 MUSCLE SPASMS 672 0.0037
735 FIBROMYALGIA 89 0.0037
736 DEPRESSION 832 0.0037
737 VISUAL IMPAIRMENT 453 0.0037
738 HAEMORRHOIDS 71 0.0036
739 ANGINA PECTORIS 104 0.0036
740 SYNCOPE 363 0.0036
741 DYSARTHRIA 136 0.0036
742 LIP SWELLING 120 0.0036
743 PERIPHERAL SWELLING 555 0.0036
744 FATIGUE 2804 0.0036
745 ERYTHEMA 740 0.0036
746 HYPERLIPIDAEMIA 43 0.0036
747 DISABILITY 71 0.0036
748 MENTAL IMPAIRMENT 87 0.0036
749 FOOT FRACTURE 68 0.0036
750 DISEASE RECURRENCE 170 0.0036
751 AGEUSIA 89 0.0036
752 ANKLE FRACTURE 55 0.0035
753 RASH GENERALISED 92 0.0035
754 SPINAL FRACTURE 71 0.0035
755 PRODUCT USE IN UNAPPROVED INDICATION 878 0.0035
756 RENAL DISORDER 165 0.0035
757 ORAL DISCOMFORT 49 0.0035
758 EATING DISORDER 75 0.0035
759 DYSPEPSIA 345 0.0035
760 BLOOD PRESSURE DECREASED 232 0.0035
761 HEMIPARESIS 59 0.0035
762 DELUSION 54 0.0035
763 LABORATORY TEST ABNORMAL 102 0.0035
764 GASTROENTERITIS VIRAL 62 0.0034
765 DIPLOPIA 89 0.0034
766 GLOMERULAR FILTRATION RATE DECREASED 42 0.0034
767 IMMUNE SYSTEM DISORDER 45 0.0034
768 FEELING COLD 95 0.0034
769 DIALYSIS 48 0.0034
770 NOCTURIA 41 0.0034
771 HEART RATE INCREASED 334 0.0034
772 MASS 47 0.0034
773 THERAPY NON-RESPONDER 151 0.0034
774 BRADYCARDIA 178 0.0034
775 TOOTH LOSS 69 0.0033
776 CATARACT 198 0.0033
777 ACUTE MYOCARDIAL INFARCTION 98 0.0033
778 DIVERTICULITIS 92 0.0033
779 COMA 158 0.0033
780 UVEITIS 45 0.0033
781 IMMUNODEFICIENCY 49 0.0033
782 LETHARGY 189 0.0033
783 INFLUENZA 366 0.0033
784 EJECTION FRACTION DECREASED 51 0.0033
785 ABDOMINAL DISCOMFORT 546 0.0033
786 COVID-19 567 0.0032
787 CHEST PAIN 598 0.0032
788 DYSKINESIA 130 0.0032
789 PALLOR 87 0.0032
790 WEIGHT DECREASED 890 0.0032
791 VERTIGO 194 0.0032
792 CYANOSIS 50 0.0032
793 SKIN FISSURES 62 0.0032
794 SOPOR 42 0.0032
795 BLOOD PRESSURE ABNORMAL 63 0.0032
796 KIDNEY INFECTION 62 0.0032
797 SKIN DISORDER 105 0.0031
798 RASH MACULAR 110 0.0031
799 OROPHARYNGEAL PAIN 290 0.0031
800 SPEECH DISORDER 164 0.0031
801 LIMB INJURY 85 0.0031
802 ABDOMINAL PAIN UPPER 643 0.0031
803 INTERVERTEBRAL DISC PROTRUSION 68 0.0031
804 HEAD DISCOMFORT 55 0.0031
805 LYMPHOMA 48 0.0031
806 EMOTIONAL DISTRESS 375 0.0031
807 COORDINATION ABNORMAL 43 0.0031
808 ARTHROPATHY 171 0.0031
809 LOSS OF CONSCIOUSNESS 394 0.0031
810 VISION BLURRED 422 0.0031
811 DRY EYE 153 0.0031
812 HYPERHIDROSIS 394 0.0031
813 PULMONARY CONGESTION 40 0.0030
814 ARTHRITIS 238 0.0030
815 DIZZINESS 1509 0.0030
816 PRODUCT PRESCRIBING ERROR 72 0.0030
817 POST PROCEDURAL COMPLICATION 58 0.0030
818 FEAR 81 0.0030
819 MIDDLE INSOMNIA 56 0.0030
820 RASH PAPULAR 67 0.0030
821 MULTIPLE FRACTURES 49 0.0030
822 PERICARDITIS 50 0.0030
823 ISCHAEMIC STROKE 53 0.0030
824 GINGIVAL BLEEDING 40 0.0029
825 PHARYNGEAL OEDEMA 45 0.0029
826 UPPER LIMB FRACTURE 58 0.0029
827 FLUID RETENTION 148 0.0029
828 NERVOUSNESS 152 0.0029
829 PARANOIA 50 0.0029
830 INSURANCE ISSUE 44 0.0029
831 HOSPITALISATION 441 0.0029
832 OSTEONECROSIS 94 0.0029
833 RETCHING 61 0.0029
834 PRODUCT PRESCRIBING ISSUE 62 0.0028
835 CHOLELITHIASIS 93 0.0028
836 PRURITUS 1088 0.0028
837 PELVIC PAIN 51 0.0028
838 ABDOMINAL DISTENSION 293 0.0028
839 POLLAKIURIA 117 0.0028
840 BONE LOSS 42 0.0028
841 RECTAL HAEMORRHAGE 120 0.0028
842 GASTRIC ULCER 53 0.0028
843 BACK DISORDER 45 0.0028
844 TOOTHACHE 50 0.0028
845 OBESITY 44 0.0028
846 DEMENTIA 77 0.0028
847 MEMORY IMPAIRMENT 378 0.0027
848 BONE DISORDER 50 0.0027
849 TREATMENT NONCOMPLIANCE 150 0.0027
850 THINKING ABNORMAL 51 0.0027
851 HAEMATOCHEZIA 151 0.0027
852 MALAISE 1197 0.0027
853 DYSGEUSIA 202 0.0027
854 INTENTIONAL PRODUCT USE ISSUE 238 0.0027
855 RESPIRATORY TRACT CONGESTION 43 0.0027
856 PULMONARY ARTERIAL HYPERTENSION 39 0.0027
857 CONTUSION 258 0.0027
858 SKIN DISCOLOURATION 123 0.0027
859 EYE PAIN 151 0.0027
860 OCULAR HYPERAEMIA 127 0.0027
861 SLEEP APNOEA SYNDROME 51 0.0027
862 HEART RATE DECREASED 92 0.0026
863 IRRITABLE BOWEL SYNDROME 56 0.0026
864 PANCREATITIS 138 0.0026
865 MALIGNANT NEOPLASM PROGRESSION 266 0.0026
866 GASTRIC DISORDER 89 0.0026
867 BLOOD PRESSURE INCREASED 395 0.0026
868 ULCER 41 0.0026
869 FEEDING DISORDER 52 0.0026
870 METASTASES TO BONE 42 0.0026
871 HYPOACUSIS 110 0.0026
872 NEPHROLITHIASIS 117 0.0025
873 HAEMORRHAGE 266 0.0025
874 RHINORRHOEA 164 0.0025
875 PRESCRIBED OVERDOSE 49 0.0025
876 HEADACHE 1573 0.0025
877 DEPRESSED MOOD 132 0.0025
878 TYPE 2 DIABETES MELLITUS 84 0.0025
879 BLOOD URINE PRESENT 47 0.0025
880 BLOOD PRESSURE FLUCTUATION 59 0.0025
881 DRY MOUTH 197 0.0024
882 ILLNESS 250 0.0024
883 SUICIDAL IDEATION 221 0.0024
884 CARDIAC DISORDER 225 0.0024
885 ALOPECIA 471 0.0024
886 SWELLING FACE 156 0.0024
887 SCAR 41 0.0024
888 DRUG INEFFECTIVE 3145 0.0024
889 NASOPHARYNGITIS 439 0.0024
890 ADVERSE DRUG REACTION 212 0.0024
891 HERNIA 45 0.0023
892 CONVULSION 133 0.0023
893 LACRIMATION INCREASED 70 0.0023
894 DIABETES MELLITUS INADEQUATE CONTROL 41 0.0023
895 AMNESIA 150 0.0023
896 ORAL HERPES 45 0.0023
897 HIP FRACTURE 74 0.0023
898 SOMNOLENCE 462 0.0023
899 DISCOMFORT 139 0.0023
900 FLATULENCE 128 0.0023
901 THERAPEUTIC PRODUCT EFFECT DECREASED 101 0.0023
902 WOUND 63 0.0023
903 GLAUCOMA 43 0.0022
904 BLOOD GLUCOSE ABNORMAL 41 0.0022
905 FRACTURE 42 0.0022
906 RHEUMATOID ARTHRITIS 250 0.0022
907 ABDOMINAL PAIN LOWER 55 0.0022
908 FEELING HOT 133 0.0022
909 MOOD ALTERED 59 0.0022
910 NASAL CONGESTION 127 0.0022
911 UNEVALUABLE EVENT 163 0.0022
912 DEATH 1855 0.0022
913 RESPIRATORY ARREST 59 0.0021
914 AGGRESSION 106 0.0021
915 TOOTH DISORDER 47 0.0021
916 EYE DISORDER 68 0.0021
917 PRODUCT USE ISSUE 387 0.0021
918 FREQUENT BOWEL MOVEMENTS 55 0.0020
919 BLINDNESS 82 0.0020
920 DIABETES MELLITUS 153 0.0020
921 FLUSHING 204 0.0020
922 INTESTINAL OBSTRUCTION 75 0.0020
923 INJURY 139 0.0020
924 PRODUCT DOSE OMISSION 129 0.0020
925 IMPAIRED HEALING 62 0.0019
926 HYPERSOMNIA 54 0.0019
927 FEELING ABNORMAL 449 0.0019
928 ECZEMA 97 0.0019
929 THERAPY INTERRUPTED 132 0.0018
930 ABORTION SPONTANEOUS 74 0.0018
931 HEAD INJURY 58 0.0018
932 DRUG ABUSE 150 0.0018
933 THERAPY CESSATION 92 0.0018
934 SYSTEMIC LUPUS ERYTHEMATOSUS 63 0.0018
935 CRYING 64 0.0018
936 MOOD SWINGS 56 0.0018
937 HOT FLUSH 132 0.0017
938 EYE SWELLING 65 0.0017
939 ABNORMAL DREAMS 48 0.0017
940 MYOCARDIAL INFARCTION 289 0.0017
941 INTENTIONAL DOSE OMISSION 47 0.0016
942 FEMUR FRACTURE 51 0.0016
943 SURGERY 96 0.0016
944 ERECTILE DYSFUNCTION 42 0.0016
945 PSORIASIS 212 0.0016
946 OVERDOSE 350 0.0016
947 WEIGHT INCREASED 363 0.0016
948 INTENTIONAL PRODUCT MISUSE 140 0.0016
949 ABNORMAL BEHAVIOUR 63 0.0016
950 ILL-DEFINED DISORDER 96 0.0016
951 INFLUENZA LIKE ILLNESS 130 0.0016
952 DRY SKIN 210 0.0016
953 MIGRAINE 149 0.0016
954 PRODUCT DOSE OMISSION ISSUE 432 0.0015
955 FOETAL EXPOSURE DURING PREGNANCY 116 0.0014
956 THROAT IRRITATION 64 0.0014
957 LUNG NEOPLASM MALIGNANT 58 0.0014
958 ROAD TRAFFIC ACCIDENT 58 0.0014
959 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 40 0.0014
960 PREMATURE BABY 41 0.0014
961 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 245 0.0014
962 ADVERSE EVENT 124 0.0013
963 BLOOD GLUCOSE DECREASED 64 0.0013
964 EMOTIONAL DISORDER 41 0.0013
965 SKIN BURNING SENSATION 95 0.0013
966 VAGINAL HAEMORRHAGE 57 0.0013
967 EXPOSURE DURING PREGNANCY 78 0.0013
968 CEREBROVASCULAR ACCIDENT 203 0.0012
969 IRRITABILITY 70 0.0012
970 EYE PRURITUS 39 0.0012
971 ANGER 39 0.0012
972 INCORRECT DOSE ADMINISTERED 255 0.0011
973 DRUG EFFECT INCOMPLETE 40 0.0011
974 BLOOD GLUCOSE INCREASED 206 0.0011
975 ACCIDENTAL OVERDOSE 39 0.0011
976 COLITIS ULCERATIVE 47 0.0011
977 NEOPLASM MALIGNANT 70 0.0010
978 THERAPEUTIC RESPONSE DECREASED 63 0.0010
979 BLOOD CHOLESTEROL INCREASED 48 0.0010
980 MATERNAL EXPOSURE DURING PREGNANCY 88 0.0010
981 SUICIDE ATTEMPT 57 0.0009
982 EYE IRRITATION 54 0.0009
983 DRUG DOSE OMISSION 155 0.0009
984 UNDERDOSE 64 0.0009
985 MULTIPLE SCLEROSIS RELAPSE 56 0.0008
986 PROSTATE CANCER 57 0.0007
987 ACNE 53 0.0007
988 INJECTION SITE PRURITUS 44 0.0007
989 NO ADVERSE EVENT 109 0.0006
990 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 118 0.0006
991 COMPLETED SUICIDE 48 0.0006
992 INJECTION SITE ERYTHEMA 67 0.0005
993 INJECTION SITE PAIN 136 0.0004
994 PRODUCT QUALITY ISSUE 54 0.0004
995 DRUG DEPENDENCE 60 0.0004